reglab/housing_qa huggingface dataset:
NJ Rev Stat § 26:2R-2 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2R-2 - Definitions relative to "Osteoporosis Prevention and Education Program Act."

26:2R-2 Definitions relative to "Osteoporosis Prevention and Education Program Act."  2. As used in this act: "Commissioner" means the Commissioner of Human Services. "Council" means the Interagency Council on Osteoporosis established pursuant to this act. "Department" means the Department of Human Services. "Program" means the osteoporosis prevention and education program established pursuant to this act. L.1997, c.191, s.2; amended 2012, c.17, s.291.
NJ Rev Stat § 26:2R-3 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2R-3 - Establishment of osteoporosis prevention and education program.

26:2R-3 Establishment of osteoporosis prevention and education program.  3. a. The Commissioner of Human Services shall establish an osteoporosis prevention and education program in the Department of Human Services. The purpose of the program is to promote: public awareness of the causes of osteoporosis; options for prevention; the value of early detection; and possible treatments, including the benefits and risks of those treatments. The department may accept, for that purpose, any special grant of money, services, or property from the federal government or any of its agencies, or from any foundation, organization, or medical school. b. The program shall include the following: (1) Development of a public education and outreach campaign to promote osteoporosis prevention and education, including, but not limited to, the following subjects: (a) The cause and nature of the disease; (b) Risk factors; (c) The role of hysterectomy; (d) Prevention of osteoporosis, including nutrition, diet, and physical exercise; (e) Diagnostic procedures and appropriate indications for their use; (f) Hormone replacement, including the benefits and risks; (g) Environmental safety and injury prevention; and (h) Availability of osteoporosis diagnostic treatment services in the community. (2) Development of educational materials to be made available for consumers, particularly targeted to high-risk groups, through local boards of health, physicians, other health care providers, including, but not limited to, health maintenance organizations, hospitals, and clinics, and women's organizations. (3) Development of professional education programs for health care providers to assist them in understanding research findings and the subjects set forth in paragraph (1) of this subsection. (4) Development and maintenance of a list of current providers of specialized services for the prevention and treatment of osteoporosis. Dissemination of the list shall be accompanied by a description of diagnostic procedures, appropriate indications for their use, and a cautionary statement about the current status of osteoporosis research, prevention, and treatment. The statement shall also indicate that the department does not license, certify, or in any other way approve osteoporosis programs or centers in this State. L.1997, c.191, s.3; amended 2012, c.17, s.292.
NJ Rev Stat § 26:2R-3.1 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2R-3.1 - Preparation, distribution of informational pamphlet on osteoporosis.

26:2R-3.1 Preparation, distribution of informational pamphlet on osteoporosis.  1. The Department of Human Services shall prepare an informational pamphlet which describes the causes and nature of osteoporosis as well as methods which may be used to prevent and treat osteoporosis, including nutrition, diet, physical exercise, and medications. The department shall make a supply of these pamphlets available to all pharmacies registered with the New Jersey Board of Pharmacy for distribution to the public. L.1999, c.330, s.1; amended 2012, c.17, s.293.
NJ Rev Stat § 26:2R-4 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2R-4 - Establishment of Interagency Council on Osteoporosis.

26:2R-4 Establishment of Interagency Council on Osteoporosis.  4. There is established an Interagency Council on Osteoporosis in the department to advise the commissioner on the development and implementation of the program. The members of the council shall be appointed by the commissioner, and shall include the following: The Director of the Division of Epidemiology, Environmental and Occupational Health Services and the Assistant Commissioner of Senior Affairs in the department and the Director of the Division on Women in the Department of Children and Families, as ex officio members, and public members who are representatives of: persons with osteoporosis; women's health organizations; public health educators; experts in bone and osteoporosis research, prevention and treatment; and health care providers, including at least one radiologist, orthopedist, registered professional nurse, physical therapist, and nutritionist. The members of the council shall serve without compensation and shall not be reimbursed for any expenses incurred by them in the performance of their duties. L.1997, c.191, s.4; amended 2012, c.16, s.49.
NJ Rev Stat § 26:2R-5 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2R-5 - Report to Governor, Legislature.

26:2R-5 Report to Governor, Legislature.  5. The commissioner shall report to the Governor and the Legislature no later than 18 months after the effective date of this act, and annually thereafter, on the activities and accomplishments of the program. L.1997,c.191,s.5.
NJ Rev Stat § 26:2R-6 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2R-6 - Rules, regulations.

26:2R-6 Rules, regulations.  6. The commissioner, pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), shall adopt rules and regulations to effectuate the purposes of this act. L.1997,c.191,s.6.
NJ Rev Stat § 26:2RR-1 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2RR-1 - Short title.

26:2RR-1 Short title.  1. This act shall be known and may be cited as the "Parkinson's Disease Public Awareness and Education Act." L.2014, c.76, s.1.
NJ Rev Stat § 26:2RR-2 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2RR-2 - Findings, declarations relative to Parkinson's disease.

26:2RR-2 Findings, declarations relative to Parkinson's disease.  2. The Legislature finds and declares that: a. Parkinson's disease is a debilitating, painful, and incurable neurological disorder of unknown origin that disrupts and can end the lives of those who suffer from it; b. Parkinson's disease causes diverse symptoms, including rigidity, slowness of movement, poor balance, and tremors, which lead to an impaired ability to walk, speak, swallow, and even breathe, so that the end result can be a clear mind trapped inside a body that has lost its ability to function; c. The visible symptoms of Parkinson's disease are often mistaken to be a normal part of the aging process; d. In addition, many people with the disease encounter precarious legal and personal situations in which they are erroneously thought to be under the influence of illegal or prescription drugs or alcohol due to their movement and gait patterns; e. Parkinson's disease takes an enormous emotional, psychological, and physical toll on caregivers and families, potentially overwhelming their lives; f. It has been estimated that 1.5 million Americans have been diagnosed with Parkinson's disease, 50,000 more are diagnosed nationally each year, and another 1.5 million persons have the disease but have never seen a neurologist; g. Parkinson's disease costs Americans $25 billion per year, including medical treatments, disability payments, and lost productivity; h. Medications can only control some of the symptoms of the disease and only for uncertain periods of time; i. New Jersey, with the largest concentration of pharmaceutical companies of any state in the nation and its top academic research facilities, is a center for Parkinson's disease research and treatment; j. The "Morris K. Udall Parkinson's Disease Research Act of 1997," Pub.L.105-78, provides federal funding through the National Institutes of Health for Parkinson's disease, and April 11 has been proclaimed to be World Parkinson's Day in order to recognize the need for more research and help in dealing with the devastating effects of this disease; k. This State, through the enactment of Joint Resolution No. 17 on January 7, 2000, has designated April in each year as "Parkinson's Disease Awareness Month" in New Jersey, and directs the Governor to annually issue a proclamation calling upon the public officials and citizens of the State to observe this month with appropriate activities and programs; l. Increased public awareness and education are needed among health care, social services, judicial, law enforcement, and emergency medical services personnel in order to better respond to the needs of Parkinson's disease patients and their caregivers and families; and m. It is imperative for New Jersey to commit itself to actively support such public awareness and education efforts throughout the State in order to better meet the needs of its citizens who are suffering from Parkinson's disease. L.2014, c.76, s.2.
NJ Rev Stat § 26:2RR-3 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2RR-3 - Definitions relative to Parkinson's disease.

26:2RR-3 Definitions relative to Parkinson's disease.  3. As used in this act: "Commissioner" means the Commissioner of Health. "Department" means the Department of Health. "Program" means the Parkinson's disease public awareness and education program established pursuant to this act. L.2014, c.76, s.3.
NJ Rev Stat § 26:2RR-4 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2RR-4 - Parkinson's disease public awareness and education program.

26:2RR-4 Parkinson's disease public awareness and education program.  4. The Commissioner of Health, subject to available appropriations, shall establish a Parkinson's disease public awareness and education program. a. The purpose of the program shall be to promote public awareness of Parkinson's disease and the value of early detection and possible treatments, including the benefits and risks of those treatments. The Department of Health may accept, for that purpose, any special grant of monies, services, or property from the federal government or any of its agencies, or from any foundation, organization, or medical school. b. The program shall include the following: (1) Development of a public education and outreach campaign to promote Parkinson's disease awareness and education, including, but not limited to, the following subjects: (a) the cause and nature of the disease; (b) diagnostic procedures and appropriate indications for their use; (c) lifestyle issues relating to how a person copes with Parkinson's disease, including, but not limited to, nutrition, diet, and physical exercise; (d) environmental safety and injury prevention; and (e) availability of Parkinson's disease diagnostic and treatment services in the community; (2) Development of educational materials to be made available to consumers through local boards of health, physicians, hospitals, and clinics; (3) Development of professional education programs for health care providers to assist them in understanding research findings and the subjects set forth in paragraph (1) of this subsection; (4) Development of educational programs for other personnel, including judicial staff, police officers, fire fighters, and social services and emergency medical service providers, to assist them in recognizing the symptoms of Parkinson's disease and understanding how to respond to the needs of persons with the disease in the course of performing their duties, including dissemination of the informational booklet prepared pursuant to section 5 of this act; and (5) Development and maintenance of a list of current providers of specialized services for the diagnosis and treatment of Parkinson's disease. Dissemination of the list shall be accompanied by a description of diagnostic procedures, appropriate indications for their use, and a cautionary statement about the current status of Parkinson's disease research and treatment. The statement shall also indicate that the department does not endorse specific Parkinson's disease programs or centers in this State. L.2014, c.76, s.4.
NJ Rev Stat § 26:2RR-5 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2RR-5 - Dissemination of information relative to Parkinson's disease.

26:2RR-5 Dissemination of information relative to Parkinson's disease.  5. The department, in consultation with the New Jersey Chapter of the American Parkinson Disease Association and the Movement Disorders Center at the Robert Wood Johnson University Medical Group, Rutgers Robert Wood Johnson Medical School, shall prepare, and make available on the department's Internet website, in English and Spanish, and in a manner that is easily understandable by a patient or other non-health care professional, information about the symptoms and treatment of Parkinson's disease and any other information that the commissioner deems to be necessary. This information may be revised by the department whenever new information about Parkinson's disease becomes available. L.2014, c.76, s.5.
NJ Rev Stat § 26:2RR-6 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2RR-6 - Rules, regulations.

26:2RR-6 Rules, regulations.  6. The Commissioner of Health, pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), may adopt rules and regulations to effectuate the purposes of this act. L.2014, c.76, s.6.
NJ Rev Stat § 26:2S-1 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2S-1 - Short title

26:2S-1 Short title  1. This act shall be known and may be cited as the "Health Care Quality Act." L.1997,c.192,s.1.
NJ Rev Stat § 26:2S-3 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2S-3 - Form to be filed by carrier; minimum information required

26:2S-3 Form to be filed by carrier; minimum information required  3. a. A carrier which offers a health benefits plan to residents of this State on the effective date of this act, shall file a form, as prescribed by the commissioner, with the department within 90 days of the effective date of this act and file a copy of the form with the Department of Banking and Insurance. A carrier authorized to issue health benefits plans in this State after the effective date of this act shall file a form with the department at least 30 days prior to the date the carrier will begin to offer a health benefits plan to residents of this State. The carrier shall file a copy of the form with the Department of Banking and Insurance. A carrier shall notify the department within 10 business days of any change in information provided on the form. b. The commissioner shall establish a form for carriers which shall request, at a minimum: (1) the official address and telephone number of the place of business of the carrier; and (2) a description of the carrier's internal patient appeals process available to covered persons to contest a denial, reduction or termination of benefits, if any. c. A health maintenance organization which holds a certificate of authority pursuant to P.L.1973, c.337 (C.26:2J-1 et seq.) shall be exempt from the filing requirements of this section but shall comply with the provisions of this act. A health maintenance organization shall be required to comply with the provisions of P.L.1973, c.337 (C.26:2J-1 et seq.) and any rules and regulations adopted pursuant thereto, except that in the event that the provisions of this act conflict with the provisions of P.L.1973, c.337, the provisions of this act shall supersede the provisions of P.L.1973, c.337. d. A carrier which issues health benefits plans utilizing a selective contracting arrangement pursuant to section 22 of P.L.1993, c.162 (C.17B:27A-54) shall be required to comply with the provisions of section 22 of P.L.1993, c.162 and any rules and regulations adopted pursuant thereto, except that in the event that the provisions of this act conflict with the provisions of section 22 of P.L.1993, c.162, the provisions of this act shall supersede the provisions of section 22 of P.L.1993, c.162. L.1997,c.192,s.3.
NJ Rev Stat § 26:2S-5.1 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2S-5.1 - Health insurance carriers to provide organ, tissue donation information to subscribers.

26:2S-5.1 Health insurance carriers to provide organ, tissue donation information to subscribers.  1. a. A carrier shall provide to subscribers written informational materials about organ and tissue donation and registration at each contract renewal. The materials shall be developed or approved by a federally designated organ procurement organization, and shall inform subscribers as to how to make an anatomical gift, including information on the registration of a gift in the Donate Life New Jersey registry.  b. For purposes of this section, "carrier," as defined in P.L.1997, c.192 (C.26:2S-1 et al.), shall also include the State Health Benefits Program and the School Employees' Health Benefits Program. L.2017, c.220, s.1.
NJ Rev Stat § 26:2S-6 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2S-6 - Designation of licensed physician as medical director for managed care

26:2S-6 Designation of licensed physician as medical director for managed care  6. a. A carrier which offers a managed care plan or uses a utilization management system in any of its health benefits plans shall designate a licensed physician to serve as medical director. The medical director, or his designee, shall be designated to serve as the medical director for medical services provided to covered persons in the State and shall be licensed to practice medicine in New Jersey. The medical director shall be responsible for treatment policies, protocols, quality assurance activities and utilization management decisions of the carrier. The treatment policies, protocols, quality assurance program and utilization management decisions of the carrier shall be based on generally accepted standards of health care practice. The quality assurance and utilization management programs shall be in accordance with standards adopted by regulation of the department pursuant to this act. b. The medical director shall ensure that: (1) Any utilization management decision to deny, reduce or terminate a health care benefit or to deny payment for a health care service, because that service is not medically necessary, shall be made by a physician. In the case of a health care service prescribed or provided by a dentist, the decision shall be made by a dentist; (2) A utilization management decision shall not retrospectively deny coverage for health care services provided to a covered person when prior approval has been obtained from the carrier for those services, unless the approval was based upon fraudulent information submitted by the covered person or the participating provider; (3) In the case of a managed care plan, a procedure is implemented whereby participating physicians and dentists have an opportunity to review and comment on all medical and surgical and dental protocols, respectively, of the carrier;  (4) The utilization management program is available on a 24-hour basis to respond to authorization requests for emergency and urgent services and is available, at a minimum, during normal working hours for inquiries and authorization requests for nonurgent health care services; and (5) In the case of a managed care plan, a covered person is permitted to: choose or change a primary care physician from among participating providers in the provider network, and, when appropriate, choose a specialist from among participating network providers following an authorized referral, if required by the carrier, and subject to the ability of the specialist to accept new patients. L.1997,c.192,s.6.
NJ Rev Stat § 26:2S-6.1 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:2S-6.1 - Managed care plan to pay full contractual rate to out-of-network provider, direct payments, certain circumstances.

26:2S-6.1 Managed care plan to pay full contractual rate to out-of-network provider, direct payments, certain circumstances.  2. a. With respect to a carrier which offers a managed care plan that provides for both in-network and out-of-network benefits, in the event that: (1) a covered person is admitted by an out-of-network health care provider to an in-network health care facility for covered, medically necessary health care services; or (2) the covered person receives covered, medically necessary health care services from an out-of-network health care provider while the covered person is a patient at an in-network health care facility and was admitted to the health care facility by an in-network provider, the carrier shall reimburse the health care facility for the services provided by the facility at the carrier's full contracted rate without any penalty for the patient's selection of an out-of-network provider, in accordance with the in-network policies and in-network copayment, coinsurance or deductible requirements of the managed care plan. b. The provisions of subsection a. of this section shall apply only if the covered person complies with the preauthorization or review requirements of the health benefits plan regarding the determination of medical necessity to access in-network inpatient benefits, as set forth in writing pursuant to section 5 of P.L.1997, c.192 (C.26:2S-5). c. With respect to a carrier which offers a managed care plan that provides for both in-network and out-of-network benefits, in the event that the covered person assigns, through an assignment of benefits, his right to receive reimbursement for medically necessary health care services to an out-of-network health care provider, the carrier shall remit payment for the reimbursement directly to the health care provider in the form of a check payable to the health care provider, or in the alternative, to the health care provider and the covered person as joint payees, with a signature line for each of the payees. Payment shall be made in accordance with the provisions of this section and P.L.1999, c.154 (C.17B:30-23 et al.). Any payment made only to the covered person rather than the health care provider under these circumstances shall be considered unpaid, and unless remitted to the health care provider within the time frames established by P.L.1999, c.154 (C.17B:30-23 et al.), shall be considered overdue and subject to an interest charge as provided in that act. L.2001, c.367, s.2; amended 2009, c.209.